Catalog # H6L-Z29-202; Size 1.0 mg
PRODUCT DESCRIPTION
Molt-4 cells are infected with the Z-29 strain of HHV-6. The cells are pelleted at day 7 after infection(~35-45% VCA positive by immunofluorescence assay) and the pellet is solubilized in 0.1 M Gycin pH 9.5 and characterized at the biochemical and immunologic levels to assure product consistency and performance.
PRODUCT COMPOSITION
The cell extract is subjected to
in vitro testing to ensure lack of infectivity. An infectivity assay is performed to indicate greater than 106 logs of kill for each lot of purified virus. The total protein concentration is determined by Pierce BCA assay.
RECOMMENDED USES
Immunodetection of antibodies to HHV-6 using solid-phase enzyme immunoassay (EIA), WIB, dot-blotting and related techniques. The material can also be used for the purification of viral proteins.
The extract is also suitable as antigen for in vitro to study cellular immunology
STORAGE AND STABILITY
The viral extract is stable for at least one year when stored at –60
oC or below. To avoid freeze-thawing, unused material should be stored in aliquots.
AVAILABILITY
Distributed in vials containing 1 mg of protein, shipped on dry ice. Protein concentration ranges from 1.0 to 1.5 mg/ml.
Custom orders are available, including specific buffer formulations and package sizes.
All products are for Research Use Only and not for
in vitro Diagnostic Use
This Package Insert is provided for product evaluation purposes only and is not intended to be used
in place of the Package Insert shipped with the product.
